Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129058) titled 'A Randomized Double-Blind Placebo Controlled Trial of Anrekefen to Reduce Postoperative Nausea and Vomiting in High-Risk Gynecological Laparoscopy Patients' on July 29.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Chaohu Hospital Affiliated to Anhui Medical University

Condition: Postoperative nausea and vomiting (PONV)

Intervention: Anrekefen Intervention Group:Based on the actual weight measured within 24 hours before the operation, calculate 1.0 µg/kg, without using ideal weight or corrected weight no additional dose ceiling without evidence is set within the BMI range of ...